Transforming AI vision into commercial success.
De-risking AI investments defining the future of health.

About SkyMedAI

We don’t just talk about the future—we shape it!

Who We Are

Dr. Amir Lahav founded SkyMedAI to redefine advisory experience.
Following a career at Harvard & Pfizer, he saw a critical need for a new standard of consulting—combining strategic agility with a multidimensional fusion of data-driven vision (Sky), clinical rigor (Med), and futuristic technology (AI).

Who We Work With

• Investors
• Health Systems
• Providers & Payers
• Medtech & Healthtech
• Pharma & Life Sciences
• Startups & Emerging Tech

What We Do

We specialize in the validation and commercialization of AI-driven solutions, providing the strategic connective tissue required to transform AI vision and clinical innovation into market success.

Elite Advisory Network

We combine 25+ years of leadership with a trusted network of 50+ expert clinicians, scientists, and top industry leaders shaping the future of health.

Core Advisory Services

• Advisory Board
• Fractional C-suite Roles
• Clinical ROI & Global Scale
• Ivestment & Capital Strategy
• GTM Strategy & Market Entry
• Clinical Trial & Commercial Agility
• AI De-risking & Due Diligence (ARIA™)

The SkyMedAI Advantage

sds

Schedule a call to learn how we can position you for success

"Following a career at Harvard Medical School and Pfizer, I founded SkyMedAI to provide the strategic agility and direct access often lacking in traditional firms.

As our client, we help you identify strategic opportunities before they become obvious, and clinical hazards before they become liabilities.

We offer the perspective that comes from deep personal experience, guiding you past the obstacles others miss. We provide world-class expertise without the layers of traditional consultancies or the overhead and commitment of C-suite hiring. We thrive on high-stakes challenges where our insights carry weight and our strategy drives measurable results.

You don't have to navigate this alone. We’ve got you!"

Amir Lahav

Founder & CEO, SkyMedAI

Clients & Partners

Beyond Logos. True Partnerships.

Medical and safety technology products

Redefining modern medicine with patient-centric, neuroscience-driven digital treatments

A cloud-based EDC platform with full DCT services

Accelerating CNS drug development through eye movement biomarkers.

Digital speech platform for clinical trials

Skin imaging & digital photography in clinical trials and cosmetic dermatology

Building AI-powered models to advance human cell repair

Agile venture studio fund dedicated to reshaping the landscape of AI startups

Wearable tech, remote patient monitoring, and in-clinic digital assessments for clinical trials.

Supporting healthcare startups with education, funding, customers, and community

Wearable tech developed with and for the deaf community

AI-powered real-time analytics for interpreting facial expressions and human behavior

Patient-friendly clinical AI platform for screening, monitoring, and diagnosing human conditions.

Devices and sensors for healthcare

End-to-end remote respiratory technology solutions

AI-Native Platform for Modern Clinical Research

Harnessing the power of AI with sound to deliver health insights

Precision wearable technology for remote activity monitoring

Vital signs monitoring & AI-powered technology for hospital care and clinical trials

Multimodal conversational AI platform for monitoring neurological and psychiatric conditions

¹Includes notable advisory work by SkyMedAI’s founder, Amir Lahav, prior to the company’s launch.

Who We Work With

Elite advisory for industries driving the future of health.

Pharma

Medtech

Health Systems

Investors

Startups

What People Say

Don't just take our word for it.

Strategic Mindset & Vision

“Dr. Lahav rewires how you think. Each conversation brings clarity, foresight, and strategic lift. His instincts on partnerships and market shifts shape the direction we’re heading.”

John Gannon, President & CEO, Blue Spark Tech

Strong Network & Connections

”Amir’s network is a strategic weapon. His personal connections with key decision-makers, combined with SkyMedAI’s team, translate access into crucial intel and real value—exactly what founders need.”

Teri Chou, PhD, Founder & CEO, Modus Health

Expert Investor Guidance

”As a serial founder, I’ve worked with many advisors. Amir stands out for his strategic clarity, scientific depth, and market instinct that drive real results. He is the collaborator you need by your side when engaging investors.”

David Fox, Angel Investor, Co-founder, Modality.AI

Top Clinical Advisory

”Dr. Lahav is among the best clinical advisors I’ve worked with. He sees patterns in nontraditional datasets and turns them into strategic advantages. He crafts narratives that give founders the confidence to engage clinicians, investors, and partners.”

Micha Breakstone, PhD, Co-Founder & CEO, Somite

Deep Regulatory Expertise

”Most FDA rejections stem from poor strategy and communication failures. Amir’s special skill is precisely anticipating what regulators care about: what they need to hear, the data they must see, and how to secure approvals for digital health and AI products.”

Jonathan Helfgott, Former FDA Senior Leadership

Go-to-Market Confidence

”Amir and SkyMedAI were outstanding. Their sophisticated strategy, sharp attention to detail, and expert product positioning pushed us to think bigger. Their coaching completely changed how we showed up in the US market to secure partnerships.”

Roy Tal, Founder & CEO, Solo AI